Health News Summary: From Tariffs to Medical Claims
The latest health news covers Mexico's screwworm detection, US pharma tariff discussions, AstraZeneca's drug price cuts, Trump's controversial medical claims, Sanofi's insulin price drop, Google and Flo Health's privacy settlement, and major drugmakers' responses to potential US tariffs.
In health news, Mexico's Senasica attributed the detection of a screwworm case in Nuevo Leon to its shared protocol with the US. Routine fly-trapping played a crucial role in identifying the New World screwworm parasite, according to the agency.
In international trade, the UK is lobbying the US to reconsider proposed pharmaceutical tariffs, after President Trump's announcement of 100% tariffs on imported drugs. Meanwhile, AstraZeneca is cutting prices for its diabetes and asthma medications for direct US patients, influenced by Trump administration demands.
Sanofi is expanding its insulin discount program to include all US patients, while Flo Health and Google face a $56 million penalty for privacy breaches. Trump's assertions about Tylenol's autism risks face backlash from medical experts, and US pharma firms are assessing their operational strategies amidst looming tariff threats.
- READ MORE ON:
- health
- tariffs
- AstraZeneca
- screwworm
- Trump
- pharmaceuticals
- Sanofi
- privacy
- insulin
- vaccine
ALSO READ
DOJ Subpoenas Fani Willis: Unraveling the Legal Tangles in Trump's Election Case
Supreme Court Faces Major Test in Trump’s Birthright Citizenship Battle
High Stakes: Trump Vs. Cook in the Fed Governance Battle
Supreme Court keeps in place Trump funding freeze that threatens billions of dollars in foreign aid, reports AP.
Unveiling Amelia: Trump's Bold Move to Declassify Earhart Records
Google News